An Open-label Study (OLE) for Non-responders of VRDN-001-101 (NCT05176639) and VRDN-001-301 (NCT06021054)
Public ClinicalTrials.gov record NCT06179875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study for Participants Who Are Non-responders at the End of Treatment Assessment on the VRDN-001-101 and VRDN-001-301 Pivotal Studies
Study identification
- NCT ID
- NCT06179875
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Viridian Therapeutics, Inc.
- Industry
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Interventions
- Veligrotug Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2024
- Primary completion
- Apr 24, 2025
- Completion
- Jun 22, 2025
- Last update posted
- Apr 29, 2026
2024 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advancing Research International, LLC | Los Angeles | California | 90023 | — |
| USC Eye Institute | Los Angeles | California | 90033 | — |
| Advancing Research International, LLC | Newport Beach | California | 90023 | — |
| Stanford Byers Eye Institute | Palo Alto | California | 94303 | — |
| Cockerham Eye Consultants, PC | San Diego | California | 92108 | — |
| University of Miami Miller School of Medicine, Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Sarasota Retina Institute | Sarasota | Florida | 34239 | — |
| Vision Medical Research | Oak Lawn | Illinois | 60453 | — |
| Ophthalmic Consultants of Boston | East Weymouth | Massachusetts | 02189 | — |
| Kahana Oculoplastic & Orbital Surgery | Livonia | Michigan | 48152 | — |
| Ophthalmic Plastic, Reconstructive, Orbital and Cosmetic Surgery | Las Vegas | Nevada | 89144 | — |
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| The Center for Eye and Facial Plastic Surgery | Somerset | New Jersey | 08873 | — |
| Hospital of the University of Pennsylvania Perleman Center | Philadelphia | Pennsylvania | 19104 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Neuro-Eye Clinical Trials | Houston | Texas | 77074 | — |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | — |
| University of Washington Medical Center | Seattle | Washington | 98104-2430 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06179875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06179875 live on ClinicalTrials.gov.